New brain imaging reveals cannabis changes adolescent dopamine activity

The role of subcortical brain tissue iron as an indicator of dopamine neurophysiology in adolescent cannabis use.

Neuropsychopharmacology : official publication of the American College of Neuropsychopharmacology • • Moderately Relevant
🤖

AI Summary

Researchers have discovered a new way to measure how cannabis use affects dopamine activity in adolescent brains. Using advanced MRI scanning, scientists measured tissue iron levels in regions of the brain responsible for dopamine production and response. In a study of 81 adolescents aged 14-17, those who used cannabis more frequently—especially those using concentrate products—showed significantly lower tissue iron levels, suggesting reduced dopamine-related brain activity. This non-invasive imaging method could help scientists better understand the neurobiological basis of cannabis use disorder in young people.

The study found strong correlations between cannabis use intensity and brain changes. Adolescents who consumed more daily concentrate hits, spent more hours feeling high, or used cannabis more frequently all showed lower tissue iron signals in key dopamine regions, with the strongest findings in the ventral tegmental area (VTA)—a brain region critical for reward and motivation. Those with more severe symptoms of cannabis use disorder also displayed these brain changes, suggesting the neurophysiological effects track with addiction severity.

The significance of these findings extends beyond just brain measurements. The results align with animal and adult studies showing that regular cannabis use dampens dopamine systems, which could help explain why some adolescents develop problematic use patterns. This new tissue iron imaging method offers a breakthrough for non-invasively monitoring neurobiological changes in young cannabis users, providing researchers and clinicians with a tool to potentially identify those at risk for developing cannabis use disorder and understand the long-term consequences of adolescent cannabis use on brain development.

📄 Original Abstract

Approximately 10-20% of U.S. adolescents report past-year cannabis use (CU). Although regular CU beginning in adolescence is expected to blunt dopamine-related neurophysiology, this hypothesis has not been tested in adolescents due to methodological limitations. However, neurophysiology contributing to dopamine can be noninvasively indexed via subcortical tissue iron measured with magnetic resonance imaging (MRI). We examined adolescent CU quantity, frequency, and problems in relation to tissue iron in regions with high dopamine activity, hypothesizing that greater CU would be linked to less tissue iron. Adolescents (n = 81; 64.2% female) aged 14-17 reporting either fewer than 5 lifetime cannabis episodes (n = 47) or more than 11 episodes (n = 34), with limited alcohol and nicotine use and no other illicit substance use, completed substance use assessments and an MRI. We calculated the inverse of the normalized T2* measurement (1/nT2*; lower values indicate less tissue iron) from resting-state functional scans by assessing relative T2* decay. 1/nT2* was estimated using subcortical masks for hypothesized regions. Lower 1/nT2* signal was associated with increased daily concentrate hits (b = -0.01, p < 0.001), cannabis hours high (b = -0.01, p = 0.016), CU frequency (b = -0.01, p = 0.01), and cannabis use disorder (CUD) severity (b = -0.01, p = 0.003). Post-hoc analyses highlighted the VTA as a key region. Results align with reduced dopamine-related neurophysiology associated with CU in adult and animal samples, and have implications for understanding adolescent CUD development. Measuring 1/nT2* offers an innovative, non-invasive method to index neurobiological alterations in adolescent CU.

Explore More Research

Stay informed about the latest cannabis science.

Your stash, decoded.